Form 13F-NT - Quarterly report filed by institutional managers, Notice:
SEC Accession No. 0001172661-16-002938
Filing Date
2016-02-16
Accepted
2016-02-16 16:25:27
Documents
1
Period of Report
2015-12-31
Effectiveness Date
2016-02-16

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-NT  
1 primary_doc.xml 13F-NT 2193
  Complete submission text file 0001172661-16-002938.txt   3277
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED CAPITAL LLC (Filer) CIK: 0001157524 (see all company filings)

EIN.: 134133323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 13F-NT | Act: 34 | File No.: 028-10410 | Film No.: 161428883